Results 241 to 250 of about 40,026,108 (306)

Past and Present Vaccinations in Sweden

Acta Paediatrica, EarlyView.
Sven Arne Silfverdal
wiley   +1 more source

Extracellular vesicles in pharmacology: Innovations in drug delivery and therapeutic applications in cancer

British Journal of Pharmacology, EarlyView.
Extracellular vesicles (EVs) are a diverse population of membrane nanoparticles secreted by nearly all cell types, playing a key role in intercellular communication by transferring bioactive macromolecular cargo. In cancer, EVs shape both the local tumour microenvironment and distant premetastatic niches.
Evangelia Pantazaka, Georgios Sivvas, Evangelia Papadimitriou, Constantinos M. Mikelis   +3 more
wiley   +1 more source

Nanoparticle-Based Antigen Delivery: Advancing Immunization Strategies against Infectious Pathogens. [PDF]

Biomater Res
Patra S, Pathan NI, Karpe YA, Gajbhiye V.   +3 more
europepmc   +1 more source

Long non‐coding RNAs at the crossroads of inflammation, cancer and angiogenesis: Molecular mechanisms and their potential as therapeutic targets

British Journal of Pharmacology, EarlyView.
Long non‐coding RNAs (lncRNAs), a broad class of non‐protein‐coding RNAs, are characterized as new regulators of gene expression at the epigenetic, transcriptional, and post‐transcriptional level. Thus, lncRNAs are involved in the regulation of physiological processes and the development of human diseases and cancer by modulating proinflammatory ...
Charlie Leboff, Pamela Calle‐Mendoza, Maria Hatziapostolou, Christos Polytarchou   +3 more
wiley   +1 more source

Core protein mutations are key determinants of hepatitis B virus replication during the hepatitis B e antigen-negative stage. [PDF]

J Gen Virol
Flichman D, García MC, Granchetti HN, Campos R, Elizalde MM.   +4 more
europepmc   +1 more source

Smart nanoparticle vaccines integrate nanotechnology artificial intelligence and immunoengineering for precision immunization. [PDF]

Discov Nano
Morshedi I, Roodaki Z, Gheibi P, Zamani G, Jaberi A, Hasan J, Chaloob S, Teymourzadeh M, KarkonShayan S.   +8 more
europepmc   +1 more source

Therapeutic hepatitis B vaccine employing DNA prime - MVA boost scheme requires additional priming with recombinant HBsAg to elicit an adequate antibody response. [PDF]

Front Immunol
Kerth HA, Kächele M, Müller N, Singh S, Tulessin M, Sacherl J, Ates Öz E, Su J, Bester R, Miko S, Steiger K, Mogler C, Busch DH, Wettengel JM, Protzer U, Kosinska AD.   +15 more
europepmc   +1 more source

Dysregulated BCR repertoire and metabolic state of HBsAg-specific B cells in chronic hepatitis B revealed by integrated single-cell analysis. [PDF]

Hepatol Commun
He M, Shen L, Li Y, Hao M, Wang B, Zhang Y, Wu M, Zhang Z, Fang Z, Yuan Z, Chen J.   +10 more
europepmc   +1 more source

Antiviral efficacy of LNP-delivered IFN-α14-ApoAI mRNA for chronic hepatitis B. [PDF]

J Virus Erad
Yang Q, Li Q, Cao J, Zhao C, Lu M, Sun S, Chen M, Chen C, Huang Y, Tao S, Chen L.   +10 more
europepmc   +1 more source